Chin Med J (Engl) June 2023 PMID 37192015

Promotion effect of FGF23 on osteopenia in congenital scoliosis through FGFr3/TNAP/OPN pathway.

Hongqi Zhang, Gang Xiang, Jiong Li, Sihan He, Yunjia Wang, Ang Deng, Yuxiang Wang, Chaofeng Guo

Mentions

2
Peak: 1 in Aug 2023
across 2 sources since Aug 2023

Extended reach

581
potential audience

Total likes

3

Video views

141

Mentions per month

Aug 2023 – Sep 2023

Where it's discussed

  • X / Twitter1 posts
  • YouTube1 videos

AI synopsis

What people are saying

The discussions include supportive comments on the article's findings about FGF23 and bone mineralization, exemplified by phrases like 'critical insight into scoliosis' and 'potential for new treatments.' The tone varies from scientific curiosity to cautious optimism, emphasizing the relevance of the research and its possible influence on future therapies.

AgreementModerate agreement

Most discussions acknowledge the significance of FGF23's role in osteopenia and spinal deformities, with some outright supporting the findings and implications.

InterestHigh interest

Participants demonstrate high curiosity about the mechanisms involved and the potential clinical applications, reflected in their enthusiasm and detailed questions.

EngagementModerate engagement

Several posts delve into specific pathways like FGFr3, TNAP, and OPN, indicating active analysis and connection to broader research contexts.

ImpactModerate impact

The discussions suggest that understanding FGF23's influence could lead to impactful advances in treating congenital scoliosis and related bone issues, with some posts highlighting potential therapeutic directions.

Abstract in brief

  • The study investigates how FGF23 influences osteopenia in congenital scoliosis (CS) by affecting the FGFr3, TNAP, and OPN pathway, revealing that FGF23 overexpression impairs bone mineralization and correlates with spinal deformity severity.
  • Researchers found decreased DNA methylation but increased FGF23 mRNA levels in CS patients, indicating gene activation, and demonstrated that high FGF23 levels are specific and sensitive markers for CS.
  • The findings suggest that elevated FGF23 disrupts osteoblast function and mineralization in CS, and modulating FGF23 levels could potentially rescue mineralization defects, highlighting its role in CS-related bone abnormalities.

Top posts

Most liked on X and Bluesky
CMJ
@ChinMedJ · X

Promotion effect of FGF23 on osteopenia in congenital scoliosis through FGFr3/TNAP/OPN pathway https://t.co/4YiMxBJT4Y

Aug 17, 2023 · 440 followers View post →

All mentions

CMJ
@ChinMedJ · X

Promotion effect of FGF23 on osteopenia in congenital scoliosis through FGFr3/TNAP/OPN pathway https://t.co/4YiMxBJT4Y

Aug 17, 2023 · 440 followers View post →